UK Surveillance of Treated Retinopathy of Prematurity

Status Completed

Clinical Trial Summary

Currently, there is little recent data on regional variations in treatment methods, neonatal units that provide retinopathy (ROP) treatment, facilities for treatment available at each unit including anaesthetic support for such preterm babies, facilities to transfer babies to units that offer treatment etc. While some parts of the UK have established neonatal networks and agreements among units for ROP treatment, in other parts, such arrangements are illdefined.

The number of babies needing ROP treatment may be higher since the introduction of revised guidelines in 2008 as earlier treatment has been shown to be beneficial. Collecting epidemiological data through the British Ophthalmic Surveillance Unit (BOSU) on the incidence of treatable ROP, the treatment methods used and facilities for treatment will provide the foundation for effective planning of resources and manpower to deal with the additional demand.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02484989
Study type	Observational [Patient Registry]
Source	Moorfields Eye Hospital NHS Foundation Trust
Contact
Status	Completed
Phase	N/A
Start date	May 2013
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05043077` - Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening	Phase 4
Completed	`NCT04838665` - Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study	Phase 4
Completed	`NCT04408807` - Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided	N/A
Recruiting	`NCT03083431` - Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity	Phase 2
Enrolling by invitation	`NCT04985448` - Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
Recruiting	`NCT02090322` - Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1	N/A
Completed	`NCT00872664` - Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids	N/A
Unknown status	`NCT00254176` - Cysteine Supplementation in Critically Ill Neonates	Phase 2/Phase 3
Completed	`NCT04101721` - Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity	Phase 3
Enrolling by invitation	`NCT02050971` - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates	Phase 1
Terminated	`NCT01335113` - A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Active, not recruiting	`NCT00027222` - The Early Treatment for Retinopathy of Prematurity Study (ETROP)	Phase 2/Phase 3
Recruiting	`NCT06109285` - Validation of i-ROP DL to Detect More Than Mild ROP	N/A
Completed	`NCT01861470` - REDEXAM - Reducing Painful Eye Examinations in Preterm Infants	N/A
Completed	`NCT02014454` - Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature	Phase 2
Terminated	`NCT00634972` - Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity	Phase 4
Completed	`NCT05701124` - Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity	Phase 3
Completed	`NCT04092127` - Pain of Premature Babies and RetCam (DOLICAM)
Not yet recruiting	`NCT06044181` - Peripheral Avascular Retina in Retinopathy of Prematurity	N/A
Completed	`NCT04621136` - PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity	Phase 1/Phase 2